Addressing significant unmet needs in the field of autoimmunity through the development of novel patented therapies for treatment of disease.

AnTolRx’s vision is to build a platform that selectively targets pathogenic immune cells providing a unique tolerogenic signal to induce an anti-inflammatory phenotype and better treat diseases.